Related Experiment Video
Updated: May 6, 2026
09:58
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
13.4K
A novel long non-coding RNA-ARA: adriamycin resistance-associated
Min Jiang1, Ou Huang2, Zuoquan Xie3
1Comprehensive Breast Health Centre, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Department of Breast Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Biochemical Pharmacology
|November 5, 2013
Summary
Long non-coding RNAs (lncRNAs) regulate cancer drug resistance. Researchers identified a novel lncRNA, ARA, which is upregulated in adriamycin-resistant cells and impacts cancer cell proliferation and migration.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- Long non-coding RNAs (lncRNAs) are critical regulators in cancer biology.
- The role of lncRNAs in adriamycin resistance is largely unknown.
- Previous studies suggest lncRNA-UCA1 induces adriamycin resistance.
Purpose of the Study:
- To investigate the role of lncRNAs in adriamycin resistance.
- To identify novel lncRNAs associated with adriamycin resistance.
- To explore the function and regulatory mechanisms of a newly identified lncRNA, ARA.
Main Methods:
- Genome-wide lncRNA microarray analysis of adriamycin-resistant and sensitive cancer cell lines.
- Validation of differentially expressed lncRNAs, including ARA.
- In vitro functional assays (siRNA knockdown) to assess ARA function.
- Microarray transcriptomic analysis to identify ARA-regulated genes and pathways.
Main Results:
- Differential expression of lncRNAs was observed between resistant and sensitive cells.
- A novel lncRNA, ARA, was identified and validated.
- ARA knockdown inhibited proliferation, induced cell death, and caused G2/M arrest and migration defects.
- ARA was found to modulate MAPK signaling, metabolism, cell cycle, and cell adhesion pathways.
Conclusions:
- lncRNAs play a significant role in adriamycin resistance.
- ARA is a novel lncRNA associated with adriamycin sensitivity and resistance.
- ARA influences key cellular processes and signaling pathways involved in cancer progression.
- These findings provide novel insights into the molecular mechanisms of adriamycin resistance at the lncRNA level.
Related Concept Videos
02:15Experimental RNAi
6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
02:23RNA Editing
8.3K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.3K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
02:39lncRNA - Long Non-coding RNAs
7.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.6K
01:23RNA Interference
24.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.4K
01:23RNA Interference
6.4K
6.4K